Therapy Areas: Inflammatory Diseases
18 January 2018 - - The US Food and Drug Administration has accepted the biologics license application from Holzkirchen, Germany-based biosimilar medicines specialist Sandoz, a Novartis division, subm...
18 January 2018 - - Canada-based regenerative medicine specialist Feldan Therapeutics has formed a joint research collaboration with South Korea-based next generation biologics developer Green Cr...
17 January 2018 - - The US Food and Drug Administration has granted fast track designation to Lexington, Massachusetts-based clinical stage biopharmaceutical company Concert Pharmaceuticals, Inc. ...
17 January 2018 - Sandoz said on Tuesday that it has successfully filed its Biologics License Application (BLA) with the US Food and Drug Administration (FDA) under the 351 (k) pathway for its propose...
16 January 2018 - The US Food and Drug Administration (FDA) has accepted from Novartis' Sandoz division the Biologics License Application submitted under the 351 (k) pathway, for proposed biosimi...
16 January 2018 - Sandoz said on Monday that it has successfully submitted its Biologics License Application (BLA) with the US Food and Drug Administration (FDA) under the 351 (k) pathway for proposed...